Straumann Holding AG (SAUHY)
USD 12.56
(2.95%)
USD 12.56
(2.95%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.37 Billion CHF | 11.84% |
| 2022 | 1.22 Billion CHF | 22.06% |
| 2021 | 1 Billion CHF | 14.23% |
| 2020 | 878.1 Million CHF | 6.29% |
| 2019 | 826.14 Million CHF | 21.49% |
| 2018 | 680.03 Million CHF | 21.39% |
| 2017 | 560.18 Million CHF | 13.46% |
| 2016 | 493.73 Million CHF | 11.07% |
| 2015 | 444.53 Million CHF | 7.75% |
| 2014 | 412.57 Million CHF | -2.44% |
| 2013 | 422.87 Million CHF | -10.46% |
| 2012 | 472.27 Million CHF | 5.27% |
| 2011 | 448.61 Million CHF | 6.13% |
| 2010 | 422.71 Million CHF | 0.29% |
| 2009 | 421.49 Million CHF | -28.69% |
| 2008 | 591.09 Million CHF | 54.48% |
| 2007 | 382.64 Million CHF | 5.35% |
| 2006 | 363.2 Million CHF | 20.34% |
| 2005 | 301.82 Million CHF | 21.75% |
| 2004 | 247.9 Million CHF | 41.21% |
| 2003 | 175.55 Million CHF | 20.43% |
| 2002 | 145.77 Million CHF | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 583.83 Million CHF | -22.25% |
| 2023 Q4 | 750.89 Million CHF | 21.45% |
| 2023 Q2 | 618.27 Million CHF | 2.62% |
| 2023 FY | 1.36 Billion CHF | 11.84% |
| 2022 Q4 | 602.46 Million CHF | 6.01% |
| 2022 Q2 | 568.32 Million CHF | 8.73% |
| 2022 FY | 1.22 Billion CHF | 22.06% |
| 2021 Q4 | 522.68 Million CHF | 11.19% |
| 2021 FY | 1 Billion CHF | 14.23% |
| 2021 Q2 | 470.06 Million CHF | 28.27% |
| 2020 Q2 | 343.54 Million CHF | -14.02% |
| 2020 FY | 878.1 Million CHF | 6.29% |
| 2020 Q4 | 366.47 Million CHF | 6.67% |
| 2019 Q2 | 426.57 Million CHF | 27.99% |
| 2019 FY | 826.14 Million CHF | 21.49% |
| 2019 Q4 | 399.56 Million CHF | -6.33% |
| 2018 FY | 680.03 Million CHF | 21.39% |
| 2018 Q2 | 361.35 Million CHF | 42.02% |
| 2018 Q4 | 333.29 Million CHF | -7.76% |
| 2017 Q4 | 254.42 Million CHF | -2.06% |
| 2017 Q2 | 259.78 Million CHF | 5.21% |
| 2017 FY | 560.18 Million CHF | 13.46% |
| 2016 Q2 | 247.4 Million CHF | 1.23% |
| 2016 FY | 493.73 Million CHF | 11.07% |
| 2016 Q4 | 246.92 Million CHF | -0.19% |
| 2015 Q4 | 244.38 Million CHF | -19.26% |
| 2015 Q2 | 302.7 Million CHF | 73.07% |
| 2015 FY | 444.53 Million CHF | 7.75% |
| 2014 Q4 | 174.89 Million CHF | -14.04% |
| 2014 FY | 412.57 Million CHF | -2.44% |
| 2014 Q2 | 203.47 Million CHF | 2.5% |
| 2013 Q2 | 214.82 Million CHF | 0.0% |
| 2013 FY | 422.87 Million CHF | -10.46% |
| 2013 Q4 | 198.51 Million CHF | -7.59% |
| 2012 Q4 | - CHF | 0.0% |
| 2012 FY | 472.27 Million CHF | 5.27% |
| 2011 Q4 | - CHF | 0.0% |
| 2011 FY | 448.61 Million CHF | 6.13% |
| 2010 FY | 422.71 Million CHF | 0.29% |
| 2010 Q4 | - CHF | 0.0% |
| 2009 FY | 421.49 Million CHF | -28.69% |
| 2009 Q4 | - CHF | 0.0% |
| 2008 FY | 591.09 Million CHF | 54.48% |
| 2007 FY | 382.64 Million CHF | 5.35% |
| 2006 FY | 363.2 Million CHF | 20.34% |
| 2005 FY | 301.82 Million CHF | 21.75% |
| 2004 FY | 247.9 Million CHF | 41.21% |
| 2003 FY | 175.55 Million CHF | 20.43% |
| 2002 FY | 145.77 Million CHF | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -48006.102% |
| Ansell Limited | 495.5 Million USD | -177.989% |
| Ansell Limited | 495.5 Million USD | -177.989% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | -1563.493% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -79485.742% |
| Psykey, Inc. | 1.21 Million USD | -113411.142% |
| ConvaTec Group Plc | 910.31 Million USD | -51.314% |
| ConvaTec Group Plc | 872.5 Million USD | -57.872% |
| Encision Inc. | 3.77 Million USD | -36371.485% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -971217.458% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -1252899.609% |
| Innovative MedTech Inc. | 6.09 Million USD | -22484.6% |
| LifePoint, Inc. | 7.42 Million USD | -18454.137% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | -21595.306% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -161003.509% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -189594.326% |
| Reflect Scientific, Inc. | 1.06 Million USD | -129394.81% |
| SmileDirectClub, Inc. | 517 Million USD | -166.427% |
| Sector 10, Inc. | 39.84 Thousand USD | -3456970.073% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 79.265% |
| SheerVision, Inc. | 2.33 Million USD | -58975.927% |
| United Health Products, Inc. | 2.42 Million USD | -56665.418% |
| Vasamed, Inc. | 4.67 Million USD | -29377.003% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -53668.165% |
| Yubo International Biotech Limited | 1.25 Million USD | -109404.919% |